These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37656779)

  • 1. Everything everywhere all at once.
    Pillai A
    Sci Immunol; 2023 Sep; 8(87):eadk4486. PubMed ID: 37656779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Unexpected Benefit of TCR Cross-Reactivity in Cancer Immunotherapy.
    Bieberich F; Reddy ST
    Cancer Res; 2023 Oct; 83(19):3168-3169. PubMed ID: 37668515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional analysis of peripheral and intratumoral neoantigen-specific TCRs identified in a patient with melanoma.
    Bräunlein E; Lupoli G; Füchsl F; Abualrous ET; de Andrade Krätzig N; Gosmann D; Wietbrock L; Lange S; Engleitner T; Lan H; Audehm S; Effenberger M; Boxberg M; Steiger K; Chang Y; Yu K; Atay C; Bassermann F; Weichert W; Busch DH; Rad R; Freund C; Antes I; Krackhardt AM
    J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34518289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis E Virus (HEV)-Specific T Cell Receptor Cross-Recognition: Implications for Immunotherapy.
    Soon CF; Zhang S; Suneetha PV; Antunes DA; Manns MP; Raha S; Schultze-Florey C; Prinz I; Wedemeyer H; Sällberg Chen M; Cornberg M
    Front Immunol; 2019; 10():2076. PubMed ID: 31552033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TCRs used in cancer gene therapy cross-react with MART-1/Melan-A tumor antigens via distinct mechanisms.
    Borbulevych OY; Santhanagopolan SM; Hossain M; Baker BM
    J Immunol; 2011 Sep; 187(5):2453-63. PubMed ID: 21795600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell Receptors Engineered
    Sharma P; Harris DT; Stone JD; Kranz DM
    Cancer Immunol Res; 2019 Dec; 7(12):2025-2035. PubMed ID: 31548259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell receptor usage by melanoma-specific clonal and highly oligoclonal tumor-infiltrating lymphocyte lines.
    Shilyansky J; Nishimura MI; Yannelli JR; Kawakami Y; Jacknin LS; Charmley P; Rosenberg SA
    Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2829-33. PubMed ID: 7511820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Papillomavirus T-Cell Cross-reactivity in Cervical Cancer: Implications for Immunotherapy Clinical Trial Design.
    Helman SR; Stevanovic S; Campbell TE; Kwong MLM; Doran SL; Faquin WC; Hinrichs CS
    JAMA Netw Open; 2018 Jul; 1(3):e180706. PubMed ID: 30646017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of T-cell receptors directed against HLA-A*01-restricted and C*07-restricted epitopes of MAGE-A3 and MAGE-A12.
    Zhu S; Van den Eynde BJ; Coulie PG; Li YF; El-Gamil M; Rosenberg SA; Robbins PF
    J Immunother; 2012; 35(9):680-8. PubMed ID: 23090077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel population of human melanoma-specific CD8 T cells recognizes Melan-AMART-1 immunodominant nonapeptide but not the corresponding decapeptide.
    Derré L; Ferber M; Touvrey C; Devevre E; Zoete V; Leimgruber A; Romero P; Michielin O; Lévy F; Speiser DE
    J Immunol; 2007 Dec; 179(11):7635-45. PubMed ID: 18025209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-throughput T cell receptor engineering by functional screening identifies candidates with enhanced potency and specificity.
    Vazquez-Lombardi R; Jung JS; Schlatter FS; Mei A; Mantuano NR; Bieberich F; Hong KL; Kucharczyk J; Kapetanovic E; Aznauryan E; Weber CR; Zippelius A; Läubli H; Reddy ST
    Immunity; 2022 Oct; 55(10):1953-1966.e10. PubMed ID: 36174557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global analysis of HLA-A2 restricted MAGE-A3 tumor antigen epitopes and corresponding TCRs in non-small cell lung cancer.
    Zhang B; Ren Z; Zhao J; Zhu Y; Huang B; Xiao C; Zhang Y; Deng J; Mao L; Tang L; Lan D; Gao L; Zhang H; Chen G; Luo OJ
    Theranostics; 2023; 13(13):4449-4468. PubMed ID: 37649599
    [No Abstract]   [Full Text] [Related]  

  • 13. Targeting of multiple tumor-associated antigens by individual T cell receptors during successful cancer immunotherapy.
    Dolton G; Rius C; Wall A; Szomolay B; Bianchi V; Galloway SAE; Hasan MS; Morin T; Caillaud ME; Thomas HL; Theaker S; Tan LR; Fuller A; Topley K; Legut M; Attaf M; Hopkins JR; Behiry E; Zabkiewicz J; Alvares C; Lloyd A; Rogers A; Henley P; Fegan C; Ottmann O; Man S; Crowther MD; Donia M; Svane IM; Cole DK; Brown PE; Rizkallah P; Sewell AK
    Cell; 2023 Aug; 186(16):3333-3349.e27. PubMed ID: 37490916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of MART-1-specific T-cell receptors: T cells utilizing distinct T-cell receptor variable and joining regions recognize the same tumor epitope.
    Cole DJ; Weil DP; Shamamian P; Rivoltini L; Kawakami Y; Topalian S; Jennings C; Eliyahu S; Rosenberg SA; Nishimura MI
    Cancer Res; 1994 Oct; 54(20):5265-8. PubMed ID: 7522957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-infiltrating human CD4
    Ahmadzadeh M; Pasetto A; Jia L; Deniger DC; Stevanović S; Robbins PF; Rosenberg SA
    Sci Immunol; 2019 Jan; 4(31):. PubMed ID: 30635355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct identification of neoantigen-specific TCRs from tumor specimens by high-throughput single-cell sequencing.
    Lu YC; Zheng Z; Lowery FJ; Gartner JJ; Prickett TD; Robbins PF; Rosenberg SA
    J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34321276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma.
    Linette GP; Stadtmauer EA; Maus MV; Rapoport AP; Levine BL; Emery L; Litzky L; Bagg A; Carreno BM; Cimino PJ; Binder-Scholl GK; Smethurst DP; Gerry AB; Pumphrey NJ; Bennett AD; Brewer JE; Dukes J; Harper J; Tayton-Martin HK; Jakobsen BK; Hassan NJ; Kalos M; June CH
    Blood; 2013 Aug; 122(6):863-71. PubMed ID: 23770775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TCR function analysis using a novel system reveals the multiple unconventional tumor-reactive T cells in human breast cancer-infiltrating lymphocytes.
    Yamaguchi S; Hamana H; Shitaoka K; Sukegawa K; Nagata T; Hayee A; Kobayashi E; Ozawa T; Fujii T; Muraguchi A; Tobe K; Kishi H
    Eur J Immunol; 2021 Sep; 51(9):2306-2316. PubMed ID: 34171120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell-receptor V gene use by CD4+ melanoma-reactive clonal and oligoclonal T-cell lines.
    Nishimura MI; Custer MC; Schwarz SL; Parker LL; Mixon A; Clay TM; Yannelli JR; Rosenberg SA
    J Immunother; 1998 Sep; 21(5):352-62. PubMed ID: 9789197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation and molecular recognition of melanoma-associated antigen-specific human γδ T cells.
    Benveniste PM; Roy S; Nakatsugawa M; Chen ELY; Nguyen L; Millar DG; Ohashi PS; Hirano N; Adams EJ; Zúñiga-Pflücker JC
    Sci Immunol; 2018 Dec; 3(30):. PubMed ID: 30552102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.